Putting the BRK on breast cancer: From molecular target to therapeutics

BReast tumor Kinase (BRK, also known as PTK6) is a non-receptor tyrosine kinase that is highly expressed in breast carcinomas while having low expression in the normal mammary gland, which hints at the oncogenic nature of this kinase in breast cancer. In the past twenty-six years since the discovery...

Descripción completa

Detalles Bibliográficos
Autores principales: Ang, Hui Li, Yuan, Yi, Lai, Xianning, Tan, Tuan Zea, Wang, Lingzhi, Huang, Benjamin BoJun, Pandey, Vijay, Huang, Ruby Yun-Ju, Lobie, Peter E., Goh, Boon Cher, Sethi, Gautam, Yap, Celestial T., Chan, Ching Wan, Lee, Soo Chin, Kumar, Alan Prem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738883/
https://www.ncbi.nlm.nih.gov/pubmed/33391524
http://dx.doi.org/10.7150/thno.49716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738883/
https://www.ncbi.nlm.nih.gov/pubmed/33391524
http://dx.doi.org/10.7150/thno.49716

Ejemplares similares